Teaser: Shugo Sasaki, M.D., Ph.D., of the University of British Columbia, wants to make beta cell replacement therapies that are “immune” to attack.
The shortage of donor beta cells and the need for strong immunosuppressive drugs to prevent immune attack make beta cell replacement available only to people with severe life-threatening unawareness of their low blood sugar, called hypoglycemia. At JDRF, we are taking a new route to beta cell replacement technologies, with the aim to develop an unlimited source of insulin-producing cells without drugs that limit your immune system’s role in fighting off infection.
Dr. Santa J. Ono, president of the University of British Columbia in Canada, describes the integration of campus commons on UBC’s Vancouver campus and how it can positively transform the campus environment for multiple stakeholders
GAITHERSBURG, Md., April 11, 2017 /3BL Media/ - In the latest chapter of the President to President series, Dr. Santa J. Ono, Ph.D., president of the University of British Columbia (UBC) in Vancouver, Canada, explains how the university restructured campus housing to accommodate UBC’s increasing enrollment.
Aviation industry, research institutions collaborate to make jet fuel from forest residues
December 2, 2015 /3BL Media/ - Boeing (NYSE: BA), the University of British Columbia (UBC) and SkyNRG, with support from Canada's aviation industry and other stakeholders, are collaborating to turn leftover branches, sawdust and other forest-industry waste into sustainable aviation biofuel.